(Q36809098)

16 August 2017

Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa (English)

1 reference

16 August 2017

0 references

0 references

Marian Loveday

8

0 references

author name string

James C M Brust

1

1 reference

16 August 2017

N Sarita Shah

2

1 reference

16 August 2017

Theo L van der Merwe

3

1 reference

16 August 2017

Sheila Bamber

4

1 reference

16 August 2017

Yuming Ning

5

1 reference

16 August 2017

Moonseong Heo

6

1 reference

16 August 2017

Anthony P Moll

7

1 reference

16 August 2017

Umesh G Lalloo

9

1 reference

16 August 2017

Gerald H Friedland

10

1 reference

16 August 2017

Neel R Gandhi

11

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

Journal of Acquired Immune Deficiency Syndromes

16 August 2017

1 reference

16 August 2017

62

1 reference

16 August 2017

4

1 reference

16 August 2017

436-440

1 reference

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Side effects associated with the treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

Multidrug-resistant tuberculosis

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641171

HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23254152

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23254152

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ethionamide-induced hypothyroidism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23254152

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAI.0B013E31828175ED

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23254152

1 reference